Mental health and pre-exposure prophylaxis (PrEP) study
Part of Mental health clinical trials.
This study looks at the mental health and emotional well-being of people taking HIV PrEP (pre-exposure prophylaxis). Researchers want to understand how PrEP users are feeling and what support they might need, which can help improve care for others in the same situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You must be currently taking HIV pre-exposure prophylaxis (PrEP) — medication to prevent HIV.
- You must receive your PrEP care at one of the clinics taking part in this study.
- You must not have an HIV diagnosis (the study excludes people already living with HIV).
- This cannot be your first PrEP appointment — you must have had at least one previous visit.
- You must be able to read and answer questionnaires in French.
- You must have French social security coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help men who have sex with men improve their mental health and consider taking PrEP, a daily pill that prevents HIV. It may help if you have mild anxiety or depression and are not currently taking PrEP.
This study tries to reduce the psychological barriers that make it hard for pregnant or postpartum women to keep taking PrEP. It may help by offering support tailored to stress, trauma symptoms, or depression—especially soon after PrEP is started.
This study looks at the mental health and emotional well-being of people living with HIV. It aims to understand how they are feeling so that better support can be provided.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at how taking PrEP (medicine to prevent HIV) affects HIV prevention and how much it costs in real life. You may be able to join if you are HIV-negative and are interested in starting, currently using, or have used PrEP before.
Hear when a new Major Depressive Disorder in Patients Taking PrEP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.